Huang is a healthcare investor focused on healthcare services and medical device companies. Since joining NEA as an Associate in 2017, she has helped source and evaluate several key investments and played a role in partnering with existing portfolio companies to add operational value and accelerate growth.
In addition to identifying new investment opportunities, Huang works closely with several existing NEA portfolio companies. She serves on the board of VytronUS and is a board observer for Aetion, Curisium, Docent Health, Paladina Health, Strive Health, Vertiflex and Welltok.
Prior to joining NEA, Huang was a member of TPG Capital’s North America Buyouts Group where she focused on private equity transactions across healthcare services, biopharma and other generalist industries.
She graduated summa cum laude from University of Pennsylvania with a B.A. in Biology and B.S.E. in Finance.
New Enterprise Associates is a global venture capital firm investing in entrepreneurs building transformational businesses across multiple stages, sectors and geographies. With more than $20 billion in cumulative committed capital since the firm’s first fund closed in 1978, NEA invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO.
NEA’s track record of investing includes more than 225 portfolio company IPOs and more than 375 acquisitions.
FinSMEs
13/06/2019